APA (7th ed.) Citation

KW, C., JK, C., A, D., M, H., HC, R., G, P., . . . M, A. (2026). Optimizing testicular cancer therapy: Survivorship perspectives on reducing late toxicities without compromising outcomes. Urologic oncology. https://doi.org/10.1016/j.urolonc.2026.05.021

Chicago Style (17th ed.) Citation

KW, Cheng, Castillo JK, Douglawi A, Hofmann M, Ruckle HC, Prakash G, Hu B, and Alsyouf M. "Optimizing Testicular Cancer Therapy: Survivorship Perspectives on Reducing Late Toxicities Without Compromising Outcomes." Urologic Oncology 2026. https://doi.org/10.1016/j.urolonc.2026.05.021.

MLA (9th ed.) Citation

KW, Cheng, et al. "Optimizing Testicular Cancer Therapy: Survivorship Perspectives on Reducing Late Toxicities Without Compromising Outcomes." Urologic Oncology, 2026, https://doi.org/10.1016/j.urolonc.2026.05.021.